Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cellularity can estimate mesenchymal stem cell concentration in bone marrow, aiding regenerative medicine.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Non-ablative Er:YAG laser effectively treats hair loss with high patient satisfaction and no side effects.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

New mouse models of Pemphigus show severe symptoms and need better treatments.

A new treatment plan helps manage folliculitis decalvans effectively.

miR-200c-3p could help diagnose and treat alopecia areata.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.

Marxan is better for designing Marine Protected Areas in the Eastern English Channel.

AI in alopecia research needs better tools for predicting treatment outcomes and ensuring fairness.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Higher inflammation markers are linked to more severe alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Fusion proteins can protect hair from heat damage.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

A new 6-point scale reliably measures heat damage to hair from styling tools.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Bimatoprost may help treat hair loss from alopecia areata.

Better documentation of alopecia areata in Black individuals is needed to improve diagnosis.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.